Available Evidence Limited but Does Not Suggest Major Adverse Outcomes with Early GLP-1 Use in Pregnancy
A target trial emulation estimated the risks associated with glucagon-like peptide-1 receptor agonist (GLP-1RA) exposure in early pregnancy. The findings…
